{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:05:57Z","timestamp":1758845157733,"version":"3.44.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,24]]},"DOI":"10.7759\/cureus.93157","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:05:32Z","timestamp":1758776732000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Human Albumin Infusion in Advanced Cirrhosis and Acute-on-Chronic Liver Failure: Implications for Renal Protection and Oncologic Outcomes"],"prefix":"10.7759","author":[{"given":"Adeel","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivam","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Kumawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FNU","family":"Muskan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FNU","family":"Komal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lachhmi","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prem","family":"Chand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.002","article-title":"Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction","volume":"75","author":"Engelmann C","year":"2021","unstructured":"Engelmann C, Cl\u00e0ria J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021, 75:S49-66. 10.1016\/j.jhep.2021.01.002","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010199","article-title":"Acute kidney injury and hepatorenal syndrome in patients with cirrhosis","volume":"13","author":"Ozturk NB","year":"2023","unstructured":"Ozturk NB, Dinc EJ, Swami A, Gurakar A. Acute kidney injury and hepatorenal syndrome in patients with cirrhosis. J Clin Med. 2023, 13:199. 10.3390\/jcm13010199","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318843","article-title":"Albumin in decompensated cirrhosis: new concepts and perspectives","volume":"69","author":"Bernardi M","year":"2020","unstructured":"Bernardi M, Angeli P, Claria J, et al.. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut. 2020, 69:1127-38. 10.1136\/gutjnl-2019-318843","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i33.4773","article-title":"Albumin administration in patients with cirrhosis: Current role and novel perspectives","volume":"28","author":"de Mattos \u00c2Z","year":"2022","unstructured":"de Mattos \u00c2Z, Simonetto DA, Terra C, et al.. Albumin administration in patients with cirrhosis: Current role and novel perspectives. World J Gastroenterol. 2022, 28:4773-86. 10.3748\/wjg.v28.i33.4773","journal-title":"World J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.70029","article-title":"Efficacy of albumin use in decompensated cirrhosis and real-world adoption in Australia","volume":"8","author":"Kalo E","year":"2024","unstructured":"Kalo E, Read S, Baig A, et al.. Efficacy of albumin use in decompensated cirrhosis and real-world adoption in Australia. JGH Open. 2024, 8:e70029. 10.1002\/jgh3.70029","journal-title":"JGH Open"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137191","article-title":"Inflammatory response in the pathogenesis and treatment of hepatocellular carcinoma: a double-edged weapon","volume":"25","author":"Galasso L","year":"2024","unstructured":"Galasso L, Cerrito L, Maccauro V, et al.. Inflammatory response in the pathogenesis and treatment of hepatocellular carcinoma: a double-edged weapon. Int J Mol Sci. 2024, 25:7191. 10.3390\/ijms25137191","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1134\/S002209302106020X","article-title":"Integrative role of albumin: Evolutionary, biochemical and pathophysiological aspects","volume":"57","author":"Belinskaia DA","year":"2021","unstructured":"Belinskaia DA, Voronina PA, Goncharov NV. Integrative role of albumin: Evolutionary, biochemical and pathophysiological aspects. J Evol Biochem Physiol. 2021, 57:1419-48. 10.1134\/S002209302106020X","journal-title":"J Evol Biochem Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"10","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Syst Rev. 2021, 10:89. 10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1524839919893361","article-title":"A review of the PubMed PICO tool: Using evidence-based practice in health education","volume":"21","author":"Brown D","year":"2020","unstructured":"Brown D. A review of the PubMed PICO tool: Using evidence-based practice in health education. Health Promot Pract. 2020, 21:496-8. 10.1177\/1524839919893361","journal-title":"Health Promot Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16020","article-title":"Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial","volume":"44","author":"Pompili E","year":"2024","unstructured":"Pompili E, Baldassarre M, Iannone G, et al.. Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial. Liver Int. 2024, 44:2108-13. 10.1111\/liv.16020","journal-title":"Liver Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31071","article-title":"Paracentesis-induced circulatory dysfunction with modest-volume paracentesis is partly ameliorated by albumin infusion in acute-on-chronic liver failure","volume":"72","author":"Arora V","year":"2020","unstructured":"Arora V, Vijayaraghavan R, Maiwall R, et al.. Paracentesis-induced circulatory dysfunction with modest-volume paracentesis is partly ameliorated by albumin infusion in acute-on-chronic liver failure. Hepatology. 2020, 72:1043-55. 10.1002\/hep.31071","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001277","article-title":"Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: Results of a pilot study","volume":"31","author":"Yosry A","year":"2019","unstructured":"Yosry A, Soliman ZA, Eletreby R, Hamza I, Ismail A, Elkady MA. Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: Results of a pilot study. Eur J Gastroenterol Hepatol. 2019, 31:345-51. 10.1097\/MEG.0000000000001277","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer TD","year":"2016","unstructured":"Boyer TD, Sanyal AJ, Wong F, et al.. Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1. Gastroenterology. 2016, 150:1579-1589.e2. 10.1053\/j.gastro.2016.02.026","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01315-1","article-title":"Role of albumin infusion in cirrhosis-associated complications","volume":"24","author":"Heybe MA","year":"2024","unstructured":"Heybe MA, Mehta KJ. Role of albumin infusion in cirrhosis-associated complications. Clin Exp Med. 2024, 24:58. 10.1007\/s10238-024-01315-1","journal-title":"Clin Exp Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100708","article-title":"Position statement on the use of albumin in liver cirrhosis","volume":"27","author":"Castro-Narro G","year":"2022","unstructured":"Castro-Narro G, Moctezuma-Vel\u00e1zquez C, Male-Vel\u00e1zquez R, et al.. Position statement on the use of albumin in liver cirrhosis. Ann Hepatol. 2022, 27:100708. 10.1016\/j.aohep.2022.100708","journal-title":"Ann Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/2050640620910339","article-title":"Albumin: Indications in chronic liver disease","volume":"8","author":"Tufoni M","year":"2020","unstructured":"Tufoni M, Zaccherini G, Caraceni P, Bernardi M. Albumin: Indications in chronic liver disease. United European Gastroenterol J. 2020, 8:528-35. 10.1177\/2050640620910339","journal-title":"United European Gastroenterol J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i41.5139","article-title":"Terlipressin and hepatorenal syndrome: What is important for nephrologists and hepatologists","volume":"16","author":"Magan AA","year":"2010","unstructured":"Magan AA, Khalil AA, Ahmed MH. Terlipressin and hepatorenal syndrome: What is important for nephrologists and hepatologists. World J Gastroenterol. 2010, 16:5139-47. 10.3748\/wjg.v16.i41.5139","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S264231","article-title":"Albumin administration is efficacious in the management of patients with cirrhosis: A systematic review of the literature","volume":"12","author":"Zaccherini G","year":"2020","unstructured":"Zaccherini G, Tufoni M, Bernardi M. Albumin administration is efficacious in the management of patients with cirrhosis: A systematic review of the literature. Hepat Med. 2020, 12:153-72. 10.2147\/HMER.S264231","journal-title":"Hepat Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2021.100547","article-title":"Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis","volume":"26","author":"Shrestha DB","year":"2021","unstructured":"Shrestha DB, Budhathoki P, Sedhai YR, et al.. Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis. Ann Hepatol. 2021, 26:100547. 10.1016\/j.aohep.2021.100547","journal-title":"Ann Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i6.106418","article-title":"Human albumin infusion for reducing hyponatremia and circulatory dysfunction in liver cirrhosis: A meta-analysis update","volume":"17","author":"Zhou HJ","year":"2025","unstructured":"Zhou HJ, Li ZQ, Dili DE, Xie Q. Human albumin infusion for reducing hyponatremia and circulatory dysfunction in liver cirrhosis: A meta-analysis update. World J Hepatol. 2025, 17:106418. 10.4254\/wjh.v17.i6.106418","journal-title":"World J Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100785","article-title":"Use of albumin infusion for cirrhosis-related complications: An international position statement","volume":"5","author":"Bai Z","year":"2023","unstructured":"Bai Z, M\u00e9ndez-S\u00e1nchez N, Romeiro FG, et al.. Use of albumin infusion for cirrhosis-related complications: An international position statement. JHEP Rep. 2023, 5:100785. 10.1016\/j.jhepr.2023.100785","journal-title":"JHEP Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al.. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023, 77:1797-835. 10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial","volume":"62","author":"Cavallin M","year":"2015","unstructured":"Cavallin M, Kamath PS, Merli M, et al.. Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial. Hepatology. 2015, 62:567-74. 10.1002\/hep.27709","journal-title":"Hepatology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/410331-efficacy-of-human-albumin-infusion-in-advanced-cirrhosis-and-acute-on-chronic-liver-failure-implications-for-renal-protection-and-oncologic-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:05:35Z","timestamp":1758776735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/410331-efficacy-of-human-albumin-infusion-in-advanced-cirrhosis-and-acute-on-chronic-liver-failure-implications-for-renal-protection-and-oncologic-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.93157","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,24]]}}}